11-Mar-2021 | Market Research Store
The Global Acute Repetitive Seizures Market Is Powered By The Surging Prevalence Of Neurological Diseases Along With The Growing Investment In The Research And Development For New Medications And Therapies.
Acute repetitive seizures is a medical condition that is also named recurrent, seizure, swarm, and crescendo seizures and generally occurs in those patients who have drug-refractory epilepsy. Many seizures (more than 3) in less than 24 hours are characteristics of acute repetitive seizures. The incidence of acute repetitive seizures, on the other hand, is unknown. Such seizures are also caused by irregular brain activity that can go unnoticed or by spontaneous body shakes that cause convulsions and unconsciousness. Acute repeated seizures encompass a wide range of epileptic seizures and can strike at any age or stage.
In 2019, demand for the acute repetitive seizures market was projected at around USD 210 million, and current and expected developments by 2026 would reach an estimated USD 3,000 million. Companies and experts predict around 46.75% growth in the worldwide acute repetitive seizures market in terms of CAGR. Emerging administration pathways for epileptic seizures, new prescription therapies, and hereditary causes linked to brain malformations and epileptic seizures are only a handful of the main factors driving the global epileptic seizures treatment industry. Furthermore, the global market for epileptic seizure therapy is increasing due to an increase in the prevalence of head trauma, coronary diseases, brain tumors, alcohol misuse, and infections.
Some of the leading and top companies in the acute repetitive seizures market contain Neurelis, Inc., Alexza Pharmaceuticals, UCB S.A., Veriton Pharma, and Valeant Pharmaceuticals North America LLC, among others. For Instance, For example, Neurelis, Inc., a San Diego-based pharmaceutical firm, filed a New Drug Application to the U.S. Food and Drug Administration in September 2018 for VALTOCO as a medication for epilepsy patients with acute repetitive seizures.
Emerging administration pathways for epileptic seizures, new prescription therapies, and hereditary causes linked to brain malformations and epileptic seizures are only a handful of the main factors driving the global epileptic seizures treatment industry. Furthermore, the global market for epileptic seizure therapy is increasing due to an increase in the prevalence of head trauma, coronary diseases, brain tumors, alcohol misuse, and infections. The rise in the number of patients with status epilepticus and acute repetitive seizures is fueling the growth of the epileptic seizures care industry. Unmet health needs for patients and caregivers, as well as the availability of cutting-edge innovation pipelines, are two major factors expected to drive business demand. This drug treatment is also considered to be very useful for people suffering from cluster seizures. However, the rising treatment and medical challenges along with the reactions affecting the body after the medications poses threat to the market growth. Nevertheless, the increasing number of clinical trials with a greater focus on the introduction of novel drugs, and a growth in demand for nasal sprays for the treatment of epilepsy provide lucrative growth opportunities for the acute repetitive seizures market growth.
The acute repetitive seizures market is segmented as product, distribution channel, and region. By product segment, the market is segmented into Diastat Rectal Gel, USL-261, AZ-002, NRL-1, and others. By distribution channel segment, the market is segmented into hospital pharmacies, online stores, and retail pharmacies. The segment of retail pharmacies dominates the market owing to the availability of medications for severe medical conditions along with the surging chain of retail pharmacies providing medications for such diseases.
In terms of geography, North America represents a higher market share for the acute repetitive seizures market followed by the European region. The reason behind the dominance is considered to be the rising number of investments from leading pharmaceutical companies for developing new and effective medicines along with the rising cases of epileptic seizures among the people in this region. The rising awareness about neurological disorders and their treatments has significantly contributed to the rising demand for acute repetitive seizures market.
Browse the full “Acute Repetitive Seizures Market By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, and Others), By Distribution Channel (Hospital Pharmacy, Specialty Clinic pharmacies, and Online stores): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026.” Report at https://www.marketresearchstore.com/market-insights/acute-repetitive-seizures-market-828548
Global Acute Repetitive Seizures Market
By Distribution Channel
Regional Segment Analysis
Market Research Store is a single destination for all types of industries, global, and regional reports. We feature large repository of latest industry reports and market statistics published by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available. Our vast database of reports enables our clients to benefit from expert insights on global industries, products, and market trends.
Market Research Store
244 Fifth Avenue, Suite N202
New York, 10001, United States
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651